In8bio Inc (INAB) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.71
• Market Cap: $16.21M
• EPS: $-5.26
• 52-Week High: $8.70
• 52-Week Low: $1.17

Market Sentiment

In8bio Inc currently has a Bullish sentiment score of 0.33.

About In8bio Inc

In8bio, Inc. is a New York-based clinical-stage biotechnology company focused on advancing innovative therapies for cancer treatment through the development of genetically modified gamma-delta T cells. By leveraging its expertise in both autologous and allogeneic cell therapies, the company is effectively targeting solid tumors and positioning itself as a leader in the immuno-oncology sector. With a strong pipeline of proprietary treatments and a dedication to addressing significant unmet nee...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for In8bio Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does INAB pay dividends?

In8bio Inc (INAB) does not currently pay a regular dividend.

What is INAB's market cap?

In8bio Inc (INAB) has a market capitalization of $16.21M with a current stock price of $1.71.